Literature DB >> 20022698

NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin.

Roman Rukwied1, Alexandra Mayer, Olga Kluschina, Otilia Obreja, Marcus Schley, Martin Schmelz.   

Abstract

Nerve growth factor (NGF) modulates sensitivity and sprouting of nociceptors. We explored the spatial and temporal sensitization induced by NGF injection (1 microg) in human skin. Hyperalgesia was investigated in 16 volunteers (36+/-9 years) at day 1, 3, 7, 21, and 49. Areas of mechanical (brush, pin-prick) and heat (43 degrees C) sensitization were mapped and thermal (heat and cold) pain thresholds, mechanical (impact stimulation) and electrically evoked pain, and axon reflex flare were assessed. No spontaneous pain or local inflammation was recorded upon NGF injection and during 49 days. Sensitization to heat was maximum at day 3 and lasted 21 days. Hyperalgesia to cold was recorded at day 7 and 21. Hypersensitivity to mechanical impact stimuli developed delayed, reached maximum at day 21, and persisted throughout 49 days. Fifty percent of all volunteers reported a static allodynia to tonic pressure until day 21. Electrical stimulation at 7.5 mA was more painful at the NGF site at day 21, which correlated significantly to maximum impact pain. Axon reflex flare was unaffected by NGF. Sensitization was limited to the NGF injection site, no touch- or pin-prick evoked secondary hyperalgesia was observed. Spatially restricted hyperalgesia indicates a peripheral rather than central mechanism. The temporal profile of lasting nociceptor sensitization suggests an altered peripheral axonal expression of sensory proteins specifically leading to mechanical and thermal sensitization. Intradermal NGF administration provokes a pattern of sensitization that can be used as experimental model for neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022698     DOI: 10.1016/j.pain.2009.11.022

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  46 in total

Review 1.  The discovery and development of analgesics: new mechanisms, new modalities.

Authors:  Gillian Burgess; Dic Williams
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

2.  Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.

Authors:  Lindsay B Conner; Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2015-12-22       Impact factor: 5.820

3.  Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms.

Authors:  Michael A Eskander; Shivani Ruparel; Dustin P Green; Paul B Chen; Elaine D Por; Nathaniel A Jeske; Xiaoli Gao; Eric R Flores; Kenneth M Hargreaves
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

4.  Screening the role of pronociceptive molecules in a rodent model of endometriosis pain.

Authors:  Pedro Alvarez; Jon D Levine
Journal:  J Pain       Date:  2014-04-20       Impact factor: 5.820

5.  C-fiber recovery cycle supernormality depends on ion concentration and ion channel permeability.

Authors:  Jenny Tigerholm; Marcus E Petersson; Otilia Obreja; Esther Eberhardt; Barbara Namer; Christian Weidner; Angelika Lampert; Richard W Carr; Martin Schmelz; Erik Fransén
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

6.  Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models.

Authors:  Peter Loudon; Pieter Siebenga; Donal Gorman; Katrina Gore; Pinky Dua; Guido van Amerongen; Justin L Hay; Geert Jan Groeneveld; Richard P Butt
Journal:  Br J Clin Pharmacol       Date:  2017-11-28       Impact factor: 4.335

Review 7.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

8.  Transmission pathways and mediators as the basis for clinical pharmacology of pain.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Tyler A Smith; Nicholas P Dueck; Mitchell J Kerfeld; Zakary J Hambsch; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-07-04       Impact factor: 5.045

9.  The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw.

Authors:  A Khodorova; G D Nicol; G Strichartz
Journal:  Neuroscience       Date:  2013-10-01       Impact factor: 3.590

Review 10.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Authors:  Xiao-juan Xu; Liang Liu; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.